MUTUAL PHARMACEUTICAL CO., INC. v. BARTLETT

No. 12-142.

133 S.Ct. 2466 (2013)

186 L.Ed.2d 607

MUTUAL PHARMACEUTICAL CO., INC., Petitioner v. Karen L. BARTLETT.

Supreme Court of United States.

Decided June 24, 2013.


Attorney(s) appearing for the Case

Jay P. Lefkowitz , New York, NY, for Petitioner.

Anthony A. Yang , for the United States as amicus curiae, supporting the Petitioner.

David C. Frederick , Washington, DC, for Respondent.

Michael W. McConnell , Michael D. Shumsky , John K. Crisham , Kirkland & Ellis LLP, Washington, DC, Jay P. Lefkowitz , P.C., Counsel of Record, Kirkland & Ellis LLP, New York, NY, for Petitioner.

Steven M. Gordon , Christine M. Craig , Shaheen & Gordon, Concord, NH, Keith M. Jensen , Jensen & Associates, PLLC, Fort Worth, TX, David C. Frederick , Counsel of Record, Brendan J. Crimmins , Joshua D. Branson , Kellogg, Huber, Hansen, Todd, Evans & Figel, P.L.L.C., Washington, DC, for Respondent.


Justice ALITO, delivered the opinion of the Court.

We must decide whether federal law pre-empts the New Hampshire design-defect claim under which respondent Karen Bartlett recovered damages from petitioner Mutual Pharmaceutical, the manufacturer of sulindac, a generic nonsteroidal anti-inflammatory drug (NSAID). New Hampshire law imposes a duty on manufacturers to ensure that the drugs they market are not unreasonably unsafe, and a drug's safety is evaluated by reference...

Let's get started

Leagle.com

Welcome to the leading source of independent legal reporting
Sign on now to see your case.
Or view more than 10 million decisions and orders.

  • Updated daily.
  • Uncompromising quality.
  • Complete, Accurate, Current.

Listed below are the cases that are cited in this Featured Case. Click the citation to see the full text of the cited case. Citations are also linked in the body of the Featured Case.

Cited Cases

  • No Cases Found

Listed below are those cases in which this Featured Case is cited. Click on the case name to see the full text of the citing case.

Citing Cases